Zobrazeno 1 - 10
of 46 665
pro vyhledávání: ''
Publikováno v:
BMJ case reports. 14(8)
Palliative care is an integral component of comprehensive cancer care that offers reasonable symptom control and a decent quality of life beyond the chance for cure.[1][1] A 50-year-old postmenopausal woman was seen in the oncology clinic with a prog
Publikováno v:
BMJ case reports. 14(7)
Metastatic cancer to the oesophagus is rare. Most cases are diagnosed at autopsy or surgery. The breast is the most common organ bearing a primary tumour. Metastatic oesophageal tumours are nearly always located in the submucosal layer with normal be
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:603-611
Background: This study aims to explore the associations of human epidermal growth factor receptor 2 (HER2) and breast cancer susceptibility gene 1 (BRCA1) expression levels with prognosis and radiation sensitivity in patients with breast cancer. Meth
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:624-635
Objective: To investigate the effect of miR-146a on the sensitivity of breast cancer cells to paclitaxel (PTX). Materials and Methods: The mRNA expressions of miR-146a in normal breast cancer cells...
Publikováno v:
Materials Today: Proceedings. 80:3286-3288
Oxidative stress is thought to have a role in the pathogenesis of hole malignancies. The purpose of current study is evaluation of Malondialdehyde (MDA), Glutathione (GSH) and Catalase (CAT) levels in women with breast cancer by comparing with women
Publikováno v:
Revista de Senología y Patología Mamaria. 35:160-166
Objective Quantitative analysis of tumor-infiltrating lymphocytes (TILs) is currently considered as a prognostic factor in several malignant tumors. The aim of our study was to assess the prognostic value of TILs in breast cancers and its association
Autor:
Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, Lieveke Ameye, Isabelle Veys, Laurence Buisseret, Patrick Neven, Donatienne Taylor, Christel Fontaine, Francois P Duhoux, Jean-Luc Canon, Hannelore Denys, Florence Coussy, Camille Chakiba, Joana Mourato Ribeiro, Martine Piccart, Christine Desmedt, Michail Ignatiadis, Philippe Aftimos
Publikováno v:
Future oncology (London, England), Vol. 18, no. 22, p. 2383-2392 (2022)
Invasive lobular carcinoma (ILC) is the most common histologic subtype of breast cancer after invasive ductal carcinoma (i.e., no special type [NST]). ILC differs from NST in clinical presentation, site-specific metastases and response to conventiona
Publikováno v:
Current Oncology; Volume 29; Issue 6; Pages: 4224-4234
The reduced cost of trastuzumab biosimilars has led to increased adoption for HER2-positive breast cancer. This review of trastuzumab biosimilars encompasses this development and real world clinical data in early breast cancer. In addition, we presen
Publikováno v:
Medicinal Chemistry. 18:589-601
Background: Breast cancer is the leading cause of cancer death in women. The current methods of chemotherapy for breast cancer generally have strong adverse reactions and drug resistance. Therefore, the discovery of novel anti-breast cancer lead comp
Autor:
Afnan K. AlHiary, Lina A. Dahabiyeh, Anas M. Abdel Rahman, James W. Dennis, Judy Pawling, Dana D. Shalabi, Bushra M. Akileh, Sanaa K. Bardaweel
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 22:1611-1621
Background: Chronic inflammation plays a crucial role in the initiation, promotion, and invasion of tumors, and thus the antiproliferative effects of numerous anti-inflammatory drugs have been frequently reported in the literature. Upregulation of th